13 results
10-K
2021 FY
LIANY
LianBio
31 Mar 22
Annual report
8:55am
develops from the cancerous transformation of cells that line the stomach. There are geographic and ethnic differences in the incidence of gastric cancer … to potentially meaningful ethnic differences in the subject population.
The NMPA now officially permits, and its predecessor agencies have permitted
10-Q/A
2021 Q3
LIANY
LianBio
10 Jan 22
Quarterly report (amended)
4:06pm
obtained from an overseas clinical trial to determine whether the data demonstrate the likelihood of ethnic sensitivity (i.e.
, whether the overseas data … ethnic inconsistencies in effectiveness and safety, we may be required to conduct a bridging pharmacokinetics trial in Chinese patients either before
10-Q
2021 Q3
LIANY
LianBio
9 Dec 21
Quarterly report
5:24pm
whether the data demonstrate the likelihood of ethnic sensitivity (i.e., whether the overseas data includes enough Chinese patients to justify safety … and efficacy for Chinese patients). If there is insufficient information or the data suggests ethnic inconsistencies in effectiveness and safety, we may
424B4
LIANY
LianBio
2 Nov 21
Prospectus supplement with pricing info
4:02pm
the data demonstrate the likelihood of ethnic sensitivity (i.e., whether the overseas data includes enough Chinese patients to justify safety and efficacy … for Chinese patients). If there is insufficient information or the data suggests ethnic inconsistencies in effectiveness and safety, we may be required
S-1/A
ynbu 18fl4j
8 Oct 21
IPO registration (amended)
5:09pm
S-1
ylz89h ct0u
1 Oct 21
IPO registration
4:52pm
DRS/A
fkv4c0a48e 23rnmri
21 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
0qoiy 2cebie00ntsrci
2 Sep 21
Draft registration statement (amended)
12:00am
DRS/A
9ap1pz0n g2e
9 Aug 21
Draft registration statement (amended)
12:00am
DRS
ttn8mrds3 dc3bg
28 Jun 21
Draft registration statement
12:00am
- Prev
- 1
- Next